v3.19.3
Note 3 - Reverse Merger (Details Textual)
1 Months Ended 3 Months Ended 9 Months Ended
May 29, 2019
USD ($)
May 03, 2019
USD ($)
shares
May 31, 2019
shares
Jun. 30, 2019
USD ($)
Sep. 30, 2019
USD ($)
Number of Shares Held by Equity Holders | shares   4,936,784      
Dividends, Total       $ 5,245,000  
Interest Expense [Member]          
Debt Instrument, Convertible, Beneficial Conversion Feature         $ 2,100,000
Alliqua Biomedical, Inc. [Member]          
Dividends, Total $ 5,245,000        
Reverse Stock Split From [Member] | Alliqua Biomedical, Inc. [Member]          
Stockholders' Equity Note, Stock Split, Conversion Ratio   6      
Alliqua Biomedical, Inc. [Member]          
Business Acquisition, Exchange Ratio   0.0359      
Intangible Assets, Net (Including Goodwill), Total   $ 0      
Merger Agreement, Percentage Ownership in Combined Company, Acquirer   86.00%      
Merger Agreement, Percentage Ownership in Combined Company, Acquiree   14.00%      
Alliqua Biomedical, Inc. [Member] | Conversion of Notes into Series B Convertible Preferred Stock [Member]          
Debt Conversion, Original Debt, Amount, Principal   $ 3,000,000      
Debt Conversion, Original Debt, Amount, Cumulative Accrued Interest   $ 203,000      
Debt Conversion, Converted Instrument, Shares Issued | shares   367,041 367,041    
Debt Instrument, Convertible, Beneficial Conversion Feature         $ 2,100,000